Closed · W81XWH-16-ERP-IDA · CFDA 12.420 · Discretionary
DoD Epilepsy Idea Development Award
Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- November 9, 2016
- Close date
- 5
- Expected awards
The verdict
DoD Epilepsy Idea Development Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.
- Varies
- award range
- Closed
- application status
- 5
- expected awards
- 12.420
- CFDA program
Archived opportunity record
DoD Epilepsy Idea Development Award is closed (last close November 9, 2016). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed November 9, 2016
Est. Total Funding
$6,800,000
Expected Awards
5
Instrument
Grant
Description
The ERP Idea Development Award (IDA) mechanism was first offered in FY15. Since then, 24 IDA applications have been received, and 5 have been recommended for funding. The intent of the ERP IDA is to solicit research to understand the magnitude and underlying mechanisms of PTE, especially in Service members and Veterans while also benefitting the civilian community. To this end, the ERP has identified FY16 Focus Areas by which the intent of the IDA mechanism can be facilitated (see Section I.B., FY16 ERP IDA Focus Areas). These should be carefully considered as part of the application process. The FY16 ERP IDA offers two levels of funding. Level I is intended to support investigator-initiated research that may be high-risk and/or high-gain. Level II is intended to support advanced studies that may be multidisciplinary in nature and/or have multiple collaborators. For the Level II Collaborator Option, applications must demonstrate how the collaborators bring their unique skills to the project, and how the work cannot be accomplished without their involvement. Collaborators are defined as individuals without whom an application cannot be completed. Level II applications including multiple collaborators should include a Collaboration Statement (Attachment 10). While not required, applications to either Level I or II should provide relevant preliminary data. Preliminary data may come from the Principal Investigator’s (PI’s) published work, pilot data, or from peer-reviewed literature. Note: When starting the pre-application process (see Section II.B., Pre-Application Submission Content), PIs should ensure that they have selected the appropriate application category (Funding Level) as described in the paragraph above. The IDA is open to PIs at or above the level of Assistant Professor (or equivalent) from any field or discipline who seek to bring their expertise to address the ERP’s mission (see Section I.A., Program Description). However, as part of the application, the PI should demonstrate that the study team has experience in both TBI and epilepsy research. FY16 ERP IDA Focus Areas: The FY16 ERP IDA is seeking applications in the Focus Areas described below. Applications should address at least one of the following FY16 ERP IDA Focus Areas. An application that proposes research outside of these FY16 ERP IDA Focus Areas is acceptable, as long as the applicant provides a strong rationale as to the relevance of the research to the ERP’s FY16 mission. • Epidemiology: Epidemiological characterization of PTE following TBI, which may include: ○ Risk factors such as demographics, genetic factors, organic head injury factors, or type of insult ○ Differentiation of PTE and Psychogenic Non-Epileptic Seizures (PNES) ○ Outcomes including latency to epilepsy, morbidities and comorbidities, and mortality ○ Pre-existing conditions including psychological and psychiatric risk factors Note: Applications proposing epidemiological research should be submitted under the Epidemiology Option. • Markers and Mechanisms: Identifying markers or mechanisms (via clinical prospective or preclinical models) that address PTE: ○ Early detection ○ Diagnosis ○ Prognosis ○ Morbidity ○ Comorbidity ○ Mortality ○ Risk stratification • Models of PTE: Development of new models or better characterization of existing etiologically relevant models for PTE, including repetitive TBI. • Psychogenic Non-Epileptic Seizures: Exploration of the epidemiology, mechanisms, risk factors, or markers of PNES subsequent to TBI. Preclinical research on non-pharmacological interventions in this population is also encouraged. Note: Research focusing on interventional clinical trials (e.g., pharmacological interventions) is strongly discouraged.
Catch-all / unrestricted eligibility mark · W81XWH-16-ERP-IDA
Grants.gov marks DoD Epilepsy Idea Development Award with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).
- Code 99
- Unrestricted / see official listing
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk 301-682-5507
More from Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Synergistic Idea Award
DoW Neurofibromatosis Investigator-Initiated Research Award
DoW Neurofibromatosis Research Academy – Scholar Award
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DOW Combat Readiness – Medical Research Program Translational Research Award
What to do next
DoD Epilepsy Idea Development Award is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |